+229.5%
MRNA vs AFRM
+195.9%
+33.6%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | AFRM | Excess | Alpha |
|---|---|---|---|---|
| 1D | -7.0% | -2.9% | -4.0% | -6.2% |
| 7D | -4.2% | -5.5% | +1.3% | -2.7% |
| 30D | +7.0% | -15.5% | +22.5% | +11.9% |
| 3M | +263.4% | -10.3% | +273.7% | +277.3% |
| 6M | +334.3% | +0.6% | +333.7% | +340.8% |
| YTD | +684.5% | -11.5% | +696.0% | +705.9% |
| 1Y | +766.2% | -16.6% | +782.8% | +798.0% |
| All | +229.5% | +195.9% | +33.6% | +151.7% |
Cumulative growth
Daily Returns
Daily percentage return beside AFRM.
Daily Out/Under-Performance
Portfolio return minus AFRM return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × AFRM return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded AFRM wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling